| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypertension | 22 | 2024 | 598 | 4.420 |
Why?
|
| Internet | 32 | 2020 | 455 | 3.120 |
Why?
|
| Malnutrition | 4 | 2022 | 44 | 2.660 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 18 | 2017 | 202 | 2.440 |
Why?
|
| Child Nutrition Disorders | 3 | 2022 | 19 | 2.360 |
Why?
|
| Female | 203 | 2024 | 30624 | 2.290 |
Why?
|
| Humans | 272 | 2025 | 58948 | 2.120 |
Why?
|
| Smoking Cessation | 22 | 2024 | 532 | 2.090 |
Why?
|
| Rural Population | 13 | 2024 | 189 | 2.060 |
Why?
|
| Papillomavirus Infections | 5 | 2020 | 123 | 1.980 |
Why?
|
| Medication Adherence | 7 | 2020 | 254 | 1.980 |
Why?
|
| Physician-Patient Relations | 11 | 2019 | 381 | 1.950 |
Why?
|
| Papillomavirus Vaccines | 4 | 2020 | 71 | 1.920 |
Why?
|
| Practice Patterns, Physicians' | 25 | 2019 | 709 | 1.910 |
Why?
|
| Cross-Sectional Studies | 43 | 2023 | 2450 | 1.900 |
Why?
|
| Male | 162 | 2024 | 27335 | 1.840 |
Why?
|
| Middle Aged | 114 | 2024 | 16160 | 1.780 |
Why?
|
| Patient Education as Topic | 17 | 2023 | 446 | 1.720 |
Why?
|
| United States | 84 | 2024 | 7451 | 1.650 |
Why?
|
| Adult | 102 | 2024 | 15632 | 1.650 |
Why?
|
| Aged | 96 | 2024 | 13241 | 1.630 |
Why?
|
| Patient Acceptance of Health Care | 10 | 2018 | 445 | 1.540 |
Why?
|
| Trust | 5 | 2019 | 63 | 1.510 |
Why?
|
| Acute Coronary Syndrome | 8 | 2019 | 256 | 1.470 |
Why?
|
| Myocardial Infarction | 19 | 2016 | 855 | 1.400 |
Why?
|
| Health Status | 7 | 2017 | 448 | 1.390 |
Why?
|
| Medicine, Traditional | 2 | 2020 | 7 | 1.370 |
Why?
|
| Alabama | 32 | 2016 | 80 | 1.340 |
Why?
|
| Healthcare Disparities | 8 | 2024 | 328 | 1.330 |
Why?
|
| Pregnancy Complications | 9 | 2024 | 388 | 1.310 |
Why?
|
| Osteoporosis | 16 | 2018 | 137 | 1.300 |
Why?
|
| Attitude to Health | 4 | 2020 | 274 | 1.300 |
Why?
|
| HIV Infections | 20 | 2023 | 915 | 1.290 |
Why?
|
| Narration | 4 | 2019 | 44 | 1.190 |
Why?
|
| Education, Medical, Continuing | 11 | 2011 | 98 | 1.180 |
Why?
|
| Research Design | 8 | 2020 | 561 | 1.160 |
Why?
|
| Depression, Postpartum | 6 | 2024 | 162 | 1.160 |
Why?
|
| Health Education | 4 | 2017 | 184 | 1.090 |
Why?
|
| Medicare | 19 | 2024 | 601 | 1.080 |
Why?
|
| Depressive Disorder | 6 | 2024 | 292 | 1.070 |
Why?
|
| Social Class | 4 | 2017 | 123 | 1.060 |
Why?
|
| Quality of Health Care | 13 | 2017 | 514 | 1.060 |
Why?
|
| Cultural Competency | 6 | 2021 | 50 | 1.050 |
Why?
|
| Uterine Cervical Neoplasms | 4 | 2020 | 145 | 1.030 |
Why?
|
| India | 12 | 2022 | 156 | 1.000 |
Why?
|
| Adolescent | 33 | 2024 | 5879 | 0.990 |
Why?
|
| Vietnam | 8 | 2024 | 160 | 0.940 |
Why?
|
| Prejudice | 2 | 2017 | 61 | 0.930 |
Why?
|
| Depression | 9 | 2024 | 856 | 0.930 |
Why?
|
| Diabetes Mellitus | 11 | 2019 | 531 | 0.930 |
Why?
|
| Models, Statistical | 6 | 2020 | 307 | 0.920 |
Why?
|
| Communication | 9 | 2021 | 531 | 0.910 |
Why?
|
| Socioeconomic Factors | 17 | 2019 | 782 | 0.900 |
Why?
|
| Income | 8 | 2019 | 158 | 0.890 |
Why?
|
| Health Knowledge, Attitudes, Practice | 11 | 2021 | 738 | 0.870 |
Why?
|
| Health Services Research | 8 | 2018 | 269 | 0.870 |
Why?
|
| Intubation, Gastrointestinal | 3 | 2013 | 24 | 0.860 |
Why?
|
| Gastrostomy | 3 | 2013 | 33 | 0.840 |
Why?
|
| Financing, Personal | 2 | 2015 | 25 | 0.840 |
Why?
|
| Enteral Nutrition | 3 | 2013 | 55 | 0.830 |
Why?
|
| Young Adult | 29 | 2024 | 4284 | 0.830 |
Why?
|
| Noncommunicable Diseases | 2 | 2019 | 16 | 0.820 |
Why?
|
| Health Services Accessibility | 10 | 2015 | 541 | 0.820 |
Why?
|
| Health Promotion | 8 | 2024 | 490 | 0.820 |
Why?
|
| Alphapapillomavirus | 2 | 2020 | 17 | 0.820 |
Why?
|
| Informed Consent | 3 | 2025 | 133 | 0.810 |
Why?
|
| Cognition | 3 | 2021 | 458 | 0.810 |
Why?
|
| Patient Selection | 9 | 2015 | 440 | 0.800 |
Why?
|
| Peer Group | 3 | 2024 | 95 | 0.800 |
Why?
|
| Patients | 2 | 2021 | 102 | 0.790 |
Why?
|
| Quality Indicators, Health Care | 14 | 2021 | 328 | 0.790 |
Why?
|
| Behavior Therapy | 7 | 2023 | 161 | 0.780 |
Why?
|
| Growth and Development | 1 | 2021 | 8 | 0.780 |
Why?
|
| Life Style | 3 | 2024 | 328 | 0.780 |
Why?
|
| Pilot Projects | 14 | 2021 | 913 | 0.770 |
Why?
|
| Achievement | 1 | 2021 | 27 | 0.770 |
Why?
|
| Internal Medicine | 9 | 2021 | 146 | 0.770 |
Why?
|
| Head and Neck Neoplasms | 3 | 2013 | 153 | 0.770 |
Why?
|
| Clinical Laboratory Services | 1 | 2021 | 5 | 0.770 |
Why?
|
| Health Behavior | 7 | 2021 | 469 | 0.770 |
Why?
|
| Medical Laboratory Personnel | 1 | 2021 | 8 | 0.770 |
Why?
|
| Residence Characteristics | 3 | 2019 | 221 | 0.770 |
Why?
|
| Patient Participation | 4 | 2019 | 208 | 0.770 |
Why?
|
| Arthroplasty, Replacement, Knee | 6 | 2024 | 124 | 0.760 |
Why?
|
| Obesity | 7 | 2017 | 1179 | 0.760 |
Why?
|
| Pregnancy | 18 | 2024 | 2334 | 0.760 |
Why?
|
| Racism | 2 | 2013 | 78 | 0.760 |
Why?
|
| Risk Factors | 37 | 2024 | 4980 | 0.750 |
Why?
|
| Culture | 5 | 2017 | 76 | 0.750 |
Why?
|
| Health Expenditures | 3 | 2018 | 115 | 0.740 |
Why?
|
| Cardiovascular Diseases | 7 | 2020 | 821 | 0.740 |
Why?
|
| Physicians | 8 | 2010 | 428 | 0.730 |
Why?
|
| Spirituality | 2 | 2018 | 47 | 0.730 |
Why?
|
| Biomedical Research | 3 | 2019 | 247 | 0.720 |
Why?
|
| Community-Based Participatory Research | 3 | 2018 | 46 | 0.720 |
Why?
|
| Logistic Models | 16 | 2024 | 1245 | 0.710 |
Why?
|
| Health Surveys | 9 | 2022 | 306 | 0.700 |
Why?
|
| Drug Prescriptions | 7 | 2010 | 188 | 0.690 |
Why?
|
| Perinatal Care | 3 | 2021 | 61 | 0.690 |
Why?
|
| Research Personnel | 2 | 2018 | 85 | 0.680 |
Why?
|
| Randomized Controlled Trials as Topic | 12 | 2021 | 662 | 0.680 |
Why?
|
| Primary Health Care | 9 | 2015 | 641 | 0.680 |
Why?
|
| Surveys and Questionnaires | 23 | 2021 | 2567 | 0.670 |
Why?
|
| Text Messaging | 4 | 2024 | 74 | 0.670 |
Why?
|
| Clinical Trials as Topic | 2 | 2025 | 435 | 0.660 |
Why?
|
| Stakeholder Participation | 1 | 2019 | 22 | 0.660 |
Why?
|
| Antihypertensive Agents | 4 | 2020 | 172 | 0.650 |
Why?
|
| Overweight | 5 | 2017 | 247 | 0.650 |
Why?
|
| Poverty | 7 | 2019 | 286 | 0.650 |
Why?
|
| Chlamydia Infections | 5 | 2005 | 77 | 0.630 |
Why?
|
| Health Policy | 3 | 2019 | 184 | 0.630 |
Why?
|
| Bias | 2 | 2019 | 107 | 0.620 |
Why?
|
| Mothers | 3 | 2018 | 261 | 0.620 |
Why?
|
| Mass Screening | 10 | 2018 | 637 | 0.620 |
Why?
|
| Models, Economic | 1 | 2018 | 39 | 0.610 |
Why?
|
| Glucocorticoids | 8 | 2015 | 167 | 0.610 |
Why?
|
| Benchmarking | 6 | 2008 | 134 | 0.610 |
Why?
|
| Public Health Surveillance | 1 | 2018 | 29 | 0.600 |
Why?
|
| Patient Reported Outcome Measures | 2 | 2024 | 117 | 0.600 |
Why?
|
| Nuclear Family | 1 | 2017 | 19 | 0.600 |
Why?
|
| Risk-Taking | 3 | 2012 | 159 | 0.600 |
Why?
|
| Ambulatory Care | 7 | 2019 | 296 | 0.600 |
Why?
|
| Peer Review | 1 | 2018 | 25 | 0.600 |
Why?
|
| Culturally Competent Care | 1 | 2018 | 15 | 0.600 |
Why?
|
| Multivariate Analysis | 20 | 2021 | 925 | 0.590 |
Why?
|
| Prevalence | 11 | 2024 | 1277 | 0.590 |
Why?
|
| Self Care | 4 | 2016 | 211 | 0.580 |
Why?
|
| Educational Status | 4 | 2016 | 270 | 0.580 |
Why?
|
| Continuity of Patient Care | 3 | 2014 | 168 | 0.580 |
Why?
|
| Quality of Life | 10 | 2024 | 1102 | 0.580 |
Why?
|
| Rural Health | 3 | 2022 | 15 | 0.570 |
Why?
|
| Smoking Prevention | 5 | 2015 | 162 | 0.570 |
Why?
|
| Internship and Residency | 8 | 2010 | 700 | 0.570 |
Why?
|
| Clinical Protocols | 2 | 2016 | 134 | 0.570 |
Why?
|
| Simulation Training | 1 | 2018 | 58 | 0.570 |
Why?
|
| Health Status Indicators | 3 | 2016 | 98 | 0.560 |
Why?
|
| Anti-HIV Agents | 8 | 2011 | 153 | 0.560 |
Why?
|
| Age Factors | 18 | 2021 | 1517 | 0.550 |
Why?
|
| Maternal Health Services | 1 | 2017 | 64 | 0.550 |
Why?
|
| Mental Health | 3 | 2019 | 346 | 0.550 |
Why?
|
| Blood Pressure | 8 | 2021 | 518 | 0.550 |
Why?
|
| Health Care Costs | 3 | 2015 | 200 | 0.550 |
Why?
|
| Quality Assurance, Health Care | 7 | 2009 | 244 | 0.550 |
Why?
|
| Aged, 80 and over | 23 | 2021 | 5056 | 0.540 |
Why?
|
| Statistics as Topic | 1 | 2017 | 147 | 0.540 |
Why?
|
| Program Development | 5 | 2017 | 210 | 0.540 |
Why?
|
| Massachusetts | 16 | 2024 | 2081 | 0.540 |
Why?
|
| Race Relations | 1 | 2016 | 3 | 0.540 |
Why?
|
| Patient Credit and Collection | 1 | 2016 | 5 | 0.540 |
Why?
|
| Socialization | 1 | 2016 | 14 | 0.540 |
Why?
|
| Community Mental Health Services | 1 | 2017 | 104 | 0.530 |
Why?
|
| Allostasis | 1 | 2016 | 22 | 0.530 |
Why?
|
| Physicians, Primary Care | 3 | 2012 | 71 | 0.530 |
Why?
|
| Friends | 1 | 2016 | 29 | 0.520 |
Why?
|
| Education, Distance | 5 | 2011 | 34 | 0.520 |
Why?
|
| Insurance, Health | 3 | 2016 | 140 | 0.520 |
Why?
|
| Survivors | 3 | 2019 | 148 | 0.510 |
Why?
|
| Self Efficacy | 2 | 2014 | 201 | 0.510 |
Why?
|
| Professional-Patient Relations | 3 | 2013 | 127 | 0.500 |
Why?
|
| Attitude of Health Personnel | 7 | 2009 | 556 | 0.500 |
Why?
|
| Prospective Studies | 14 | 2023 | 3079 | 0.490 |
Why?
|
| Chlamydia trachomatis | 2 | 2005 | 57 | 0.490 |
Why?
|
| Universities | 5 | 2019 | 151 | 0.480 |
Why?
|
| Cohort Studies | 19 | 2021 | 2429 | 0.470 |
Why?
|
| Motor Activity | 2 | 2015 | 342 | 0.470 |
Why?
|
| Colorectal Neoplasms | 3 | 2017 | 254 | 0.460 |
Why?
|
| Electronic Health Records | 3 | 2016 | 346 | 0.460 |
Why?
|
| Marketing of Health Services | 2 | 2011 | 23 | 0.460 |
Why?
|
| Nonprescription Drugs | 3 | 2009 | 17 | 0.460 |
Why?
|
| Physicians, Family | 3 | 2009 | 75 | 0.450 |
Why?
|
| Social Discrimination | 1 | 2014 | 15 | 0.450 |
Why?
|
| Psychometrics | 6 | 2017 | 353 | 0.450 |
Why?
|
| Arthritis | 4 | 2009 | 49 | 0.450 |
Why?
|
| Electronic Mail | 4 | 2015 | 45 | 0.450 |
Why?
|
| Managed Care Programs | 9 | 2017 | 93 | 0.440 |
Why?
|
| Child | 8 | 2023 | 4250 | 0.440 |
Why?
|
| Mindfulness | 3 | 2021 | 64 | 0.440 |
Why?
|
| Stress, Psychological | 5 | 2021 | 439 | 0.440 |
Why?
|
| Retrospective Studies | 29 | 2017 | 5939 | 0.430 |
Why?
|
| Patient Compliance | 7 | 2021 | 370 | 0.430 |
Why?
|
| Sex Factors | 10 | 2021 | 957 | 0.430 |
Why?
|
| Southeastern United States | 8 | 2013 | 24 | 0.420 |
Why?
|
| Comorbidity | 14 | 2020 | 1084 | 0.420 |
Why?
|
| Pharmacies | 3 | 2010 | 36 | 0.420 |
Why?
|
| Drug Industry | 2 | 2010 | 40 | 0.410 |
Why?
|
| Cross-Over Studies | 1 | 2013 | 148 | 0.410 |
Why?
|
| Hospitals | 4 | 2017 | 373 | 0.410 |
Why?
|
| Hospitalization | 8 | 2017 | 1272 | 0.410 |
Why?
|
| Creatinine | 4 | 2016 | 121 | 0.410 |
Why?
|
| Bone Density | 6 | 2018 | 173 | 0.410 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 2023 | 137 | 0.400 |
Why?
|
| Medicaid | 4 | 2023 | 334 | 0.400 |
Why?
|
| Stroke | 4 | 2017 | 1135 | 0.400 |
Why?
|
| Thrombolytic Therapy | 3 | 2005 | 180 | 0.400 |
Why?
|
| Time Factors | 20 | 2019 | 3551 | 0.390 |
Why?
|
| Smoking | 9 | 2024 | 829 | 0.390 |
Why?
|
| Mental Health Services | 1 | 2015 | 298 | 0.390 |
Why?
|
| Health Services | 3 | 2017 | 85 | 0.390 |
Why?
|
| Computer-Assisted Instruction | 4 | 2011 | 80 | 0.380 |
Why?
|
| Delivery of Health Care | 6 | 2022 | 419 | 0.380 |
Why?
|
| Data Collection | 8 | 2019 | 382 | 0.380 |
Why?
|
| Program Evaluation | 4 | 2017 | 478 | 0.380 |
Why?
|
| Gastroscopy | 1 | 2011 | 24 | 0.380 |
Why?
|
| Follow-Up Studies | 10 | 2020 | 2316 | 0.380 |
Why?
|
| Medical Records | 3 | 2009 | 137 | 0.380 |
Why?
|
| Fibrinolytic Agents | 3 | 2006 | 164 | 0.370 |
Why?
|
| Mobile Applications | 3 | 2023 | 124 | 0.370 |
Why?
|
| Life Change Events | 1 | 2011 | 65 | 0.360 |
Why?
|
| Patient Care | 1 | 2011 | 76 | 0.360 |
Why?
|
| Chronic Disease | 3 | 2009 | 731 | 0.360 |
Why?
|
| Guideline Adherence | 9 | 2013 | 295 | 0.350 |
Why?
|
| Preventive Medicine | 3 | 2006 | 25 | 0.350 |
Why?
|
| Editorial Policies | 1 | 2011 | 53 | 0.350 |
Why?
|
| Kidney Failure, Chronic | 3 | 2008 | 188 | 0.350 |
Why?
|
| Bone Density Conservation Agents | 4 | 2013 | 48 | 0.350 |
Why?
|
| Case-Control Studies | 1 | 2013 | 1048 | 0.340 |
Why?
|
| Postpartum Period | 3 | 2024 | 201 | 0.340 |
Why?
|
| Republic of Korea | 2 | 2019 | 27 | 0.340 |
Why?
|
| Algorithms | 7 | 2022 | 982 | 0.340 |
Why?
|
| Social Support | 5 | 2019 | 357 | 0.340 |
Why?
|
| Self Disclosure | 2 | 2006 | 37 | 0.340 |
Why?
|
| Women's Health Services | 3 | 2005 | 31 | 0.330 |
Why?
|
| Happiness | 1 | 2009 | 9 | 0.330 |
Why?
|
| Health Services Needs and Demand | 3 | 2009 | 213 | 0.330 |
Why?
|
| Data Interpretation, Statistical | 4 | 2016 | 196 | 0.330 |
Why?
|
| Treatment Outcome | 18 | 2024 | 5116 | 0.330 |
Why?
|
| Geriatric Assessment | 2 | 2013 | 161 | 0.330 |
Why?
|
| Reminder Systems | 3 | 2011 | 71 | 0.330 |
Why?
|
| Cost-Benefit Analysis | 4 | 2020 | 286 | 0.330 |
Why?
|
| Infant | 3 | 2024 | 1512 | 0.330 |
Why?
|
| Motivation | 6 | 2021 | 266 | 0.330 |
Why?
|
| Risk Assessment | 11 | 2020 | 1894 | 0.330 |
Why?
|
| Kangaroo-Mother Care Method | 2 | 2021 | 7 | 0.330 |
Why?
|
| Hospitals, Urban | 2 | 2008 | 44 | 0.320 |
Why?
|
| Focus Groups | 5 | 2017 | 290 | 0.320 |
Why?
|
| Pharmacists | 2 | 2010 | 123 | 0.320 |
Why?
|
| Counseling | 6 | 2019 | 351 | 0.320 |
Why?
|
| Fractures, Spontaneous | 3 | 2007 | 7 | 0.320 |
Why?
|
| Religion | 2 | 2019 | 33 | 0.310 |
Why?
|
| Hospitals, Rural | 1 | 2008 | 21 | 0.310 |
Why?
|
| Health Care Surveys | 8 | 2009 | 278 | 0.310 |
Why?
|
| Georgia | 6 | 2019 | 87 | 0.310 |
Why?
|
| Professional Competence | 1 | 2009 | 89 | 0.310 |
Why?
|
| Information Services | 2 | 2012 | 34 | 0.300 |
Why?
|
| Medical Audit | 5 | 2009 | 60 | 0.300 |
Why?
|
| Proportional Hazards Models | 10 | 2017 | 674 | 0.290 |
Why?
|
| United States Department of Veterans Affairs | 5 | 2016 | 506 | 0.290 |
Why?
|
| Pediatrics | 3 | 2009 | 252 | 0.290 |
Why?
|
| Practice Guidelines as Topic | 9 | 2013 | 701 | 0.290 |
Why?
|
| Kidney Diseases | 2 | 2006 | 157 | 0.290 |
Why?
|
| Rural Health Services | 3 | 2012 | 30 | 0.290 |
Why?
|
| Patient Transfer | 1 | 2008 | 92 | 0.290 |
Why?
|
| Minority Groups | 4 | 2021 | 140 | 0.290 |
Why?
|
| Pain Measurement | 4 | 2019 | 327 | 0.290 |
Why?
|
| Diabetes Complications | 2 | 2007 | 102 | 0.290 |
Why?
|
| Infant, Newborn | 5 | 2024 | 1303 | 0.280 |
Why?
|
| Community Health Workers | 3 | 2020 | 37 | 0.280 |
Why?
|
| Mental Disorders | 4 | 2021 | 763 | 0.280 |
Why?
|
| Social Media | 2 | 2021 | 112 | 0.280 |
Why?
|
| Musculoskeletal Diseases | 1 | 2008 | 101 | 0.280 |
Why?
|
| Adaptation, Psychological | 3 | 2020 | 263 | 0.280 |
Why?
|
| Peptic Ulcer | 2 | 2022 | 21 | 0.270 |
Why?
|
| Fractures, Bone | 4 | 2011 | 137 | 0.270 |
Why?
|
| Patient Discharge | 4 | 2019 | 477 | 0.270 |
Why?
|
| Longitudinal Studies | 8 | 2019 | 1202 | 0.270 |
Why?
|
| Odds Ratio | 8 | 2019 | 770 | 0.270 |
Why?
|
| CD4 Lymphocyte Count | 8 | 2011 | 92 | 0.270 |
Why?
|
| Drug Labeling | 3 | 2010 | 27 | 0.270 |
Why?
|
| Health Personnel | 5 | 2019 | 340 | 0.260 |
Why?
|
| Medical History Taking | 1 | 2006 | 57 | 0.260 |
Why?
|
| Intention | 2 | 2024 | 66 | 0.260 |
Why?
|
| Acetaminophen | 1 | 2006 | 52 | 0.260 |
Why?
|
| Home Care Services | 3 | 2013 | 101 | 0.250 |
Why?
|
| Self Report | 6 | 2023 | 365 | 0.250 |
Why?
|
| Students, Medical | 2 | 2019 | 239 | 0.250 |
Why?
|
| Evidence-Based Medicine | 3 | 2011 | 455 | 0.250 |
Why?
|
| Community Medicine | 1 | 2004 | 6 | 0.240 |
Why?
|
| Health Planning Guidelines | 2 | 2008 | 30 | 0.240 |
Why?
|
| Arthroplasty, Replacement, Hip | 2 | 2017 | 63 | 0.240 |
Why?
|
| Antirheumatic Agents | 4 | 2008 | 211 | 0.230 |
Why?
|
| Exercise | 4 | 2016 | 903 | 0.230 |
Why?
|
| Sensitivity and Specificity | 6 | 2013 | 1090 | 0.230 |
Why?
|
| Adrenergic beta-Antagonists | 3 | 2010 | 149 | 0.230 |
Why?
|
| Population Surveillance | 4 | 2018 | 205 | 0.230 |
Why?
|
| Arthralgia | 2 | 2015 | 59 | 0.230 |
Why?
|
| Information Dissemination | 4 | 2013 | 113 | 0.230 |
Why?
|
| Arthritis, Rheumatoid | 4 | 2008 | 322 | 0.230 |
Why?
|
| Nurse Practitioners | 3 | 2021 | 115 | 0.230 |
Why?
|
| Teacher Training | 1 | 2023 | 2 | 0.220 |
Why?
|
| Education, Medical | 3 | 2019 | 175 | 0.220 |
Why?
|
| Contraception Behavior | 1 | 2024 | 35 | 0.220 |
Why?
|
| Angina, Unstable | 4 | 2006 | 58 | 0.220 |
Why?
|
| Antiretroviral Therapy, Highly Active | 5 | 2011 | 94 | 0.220 |
Why?
|
| Comprehension | 1 | 2025 | 126 | 0.220 |
Why?
|
| Reproducibility of Results | 7 | 2017 | 1538 | 0.220 |
Why?
|
| Disability Evaluation | 2 | 2015 | 214 | 0.220 |
Why?
|
| Medical Errors | 1 | 2005 | 181 | 0.220 |
Why?
|
| Contraception | 1 | 2024 | 64 | 0.220 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2023 | 36 | 0.220 |
Why?
|
| Vaccination | 3 | 2020 | 335 | 0.220 |
Why?
|
| Developing Countries | 3 | 2019 | 81 | 0.220 |
Why?
|
| Aging | 1 | 2009 | 720 | 0.220 |
Why?
|
| Cluster Analysis | 6 | 2019 | 249 | 0.220 |
Why?
|
| Health Records, Personal | 2 | 2016 | 26 | 0.220 |
Why?
|
| Drug Utilization | 5 | 2013 | 223 | 0.220 |
Why?
|
| Dental Health Services | 2 | 2013 | 14 | 0.210 |
Why?
|
| Adenoma | 1 | 2023 | 62 | 0.210 |
Why?
|
| Esophagitis | 1 | 2022 | 9 | 0.210 |
Why?
|
| Diffusion of Innovation | 2 | 2018 | 55 | 0.210 |
Why?
|
| Cause of Death | 2 | 2020 | 200 | 0.210 |
Why?
|
| Health Status Disparities | 2 | 2015 | 147 | 0.210 |
Why?
|
| Referral and Consultation | 3 | 2017 | 406 | 0.200 |
Why?
|
| Anxiety Disorders | 1 | 2024 | 189 | 0.200 |
Why?
|
| Knee Joint | 2 | 2015 | 283 | 0.200 |
Why?
|
| Gastroesophageal Reflux | 1 | 2022 | 76 | 0.200 |
Why?
|
| Growth Disorders | 1 | 2022 | 30 | 0.200 |
Why?
|
| Confidentiality | 2 | 2019 | 52 | 0.190 |
Why?
|
| Atrial Fibrillation | 3 | 2019 | 794 | 0.190 |
Why?
|
| Education, Nursing | 2 | 2021 | 40 | 0.190 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2022 | 93 | 0.190 |
Why?
|
| Stress Disorders, Post-Traumatic | 2 | 2024 | 363 | 0.190 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 3 | 2014 | 51 | 0.190 |
Why?
|
| Activities of Daily Living | 4 | 2017 | 297 | 0.190 |
Why?
|
| Pain | 3 | 2009 | 406 | 0.190 |
Why?
|
| Patient Readmission | 3 | 2015 | 416 | 0.190 |
Why?
|
| Peer Influence | 1 | 2021 | 6 | 0.190 |
Why?
|
| Pain, Postoperative | 2 | 2019 | 126 | 0.190 |
Why?
|
| Students | 2 | 2023 | 207 | 0.190 |
Why?
|
| Probability | 1 | 2021 | 171 | 0.190 |
Why?
|
| Clinical Competence | 6 | 2011 | 669 | 0.190 |
Why?
|
| General Practitioners | 1 | 2021 | 15 | 0.190 |
Why?
|
| Hospitals, Teaching | 2 | 2004 | 101 | 0.190 |
Why?
|
| Quality Improvement | 3 | 2016 | 412 | 0.190 |
Why?
|
| Hospital Administration | 2 | 2013 | 41 | 0.180 |
Why?
|
| Awareness | 2 | 2014 | 71 | 0.180 |
Why?
|
| Gastrointestinal Diseases | 6 | 2007 | 72 | 0.180 |
Why?
|
| Fee-for-Service Plans | 4 | 2017 | 67 | 0.180 |
Why?
|
| Tobacco Use Cessation | 2 | 2013 | 30 | 0.180 |
Why?
|
| Health Maintenance Organizations | 3 | 2007 | 87 | 0.180 |
Why?
|
| Smokers | 4 | 2023 | 108 | 0.180 |
Why?
|
| Amygdala | 1 | 2021 | 78 | 0.180 |
Why?
|
| Osteoarthritis, Knee | 2 | 2024 | 382 | 0.180 |
Why?
|
| Patient Simulation | 1 | 2021 | 66 | 0.180 |
Why?
|
| Factor Analysis, Statistical | 2 | 2014 | 104 | 0.180 |
Why?
|
| Medical Assistance | 2 | 2011 | 10 | 0.170 |
Why?
|
| Nerve Net | 1 | 2021 | 94 | 0.170 |
Why?
|
| Sexual Behavior | 3 | 2021 | 187 | 0.170 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2007 | 579 | 0.170 |
Why?
|
| Hospital Mortality | 2 | 2004 | 841 | 0.170 |
Why?
|
| Psychological Techniques | 1 | 2019 | 5 | 0.170 |
Why?
|
| Interrupted Time Series Analysis | 1 | 2019 | 28 | 0.170 |
Why?
|
| Insurance Claim Review | 2 | 2015 | 80 | 0.170 |
Why?
|
| Psychosocial Support Systems | 1 | 2019 | 11 | 0.170 |
Why?
|
| Sample Size | 1 | 2019 | 59 | 0.170 |
Why?
|
| Social Determinants of Health | 2 | 2021 | 114 | 0.170 |
Why?
|
| Veterans | 3 | 2017 | 716 | 0.170 |
Why?
|
| Electrocardiography | 3 | 2018 | 521 | 0.160 |
Why?
|
| Urban Population | 3 | 2019 | 182 | 0.160 |
Why?
|
| Electronic Nicotine Delivery Systems | 1 | 2020 | 69 | 0.160 |
Why?
|
| Mortality | 2 | 2019 | 158 | 0.160 |
Why?
|
| Health Literacy | 2 | 2010 | 76 | 0.160 |
Why?
|
| Computer User Training | 1 | 1999 | 7 | 0.160 |
Why?
|
| MEDLINE | 1 | 1999 | 19 | 0.160 |
Why?
|
| Health Priorities | 1 | 1999 | 20 | 0.160 |
Why?
|
| Body Mass Index | 4 | 2021 | 890 | 0.160 |
Why?
|
| Cigarette Smoking | 1 | 2019 | 52 | 0.160 |
Why?
|
| Breast Feeding | 2 | 2021 | 138 | 0.160 |
Why?
|
| Weight Loss | 1 | 2021 | 259 | 0.150 |
Why?
|
| Monitoring, Physiologic | 2 | 2017 | 151 | 0.150 |
Why?
|
| Health Communication | 1 | 2018 | 31 | 0.150 |
Why?
|
| Community Participation | 2 | 2011 | 43 | 0.150 |
Why?
|
| Information Storage and Retrieval | 1 | 1999 | 79 | 0.150 |
Why?
|
| Education, Medical, Graduate | 1 | 2021 | 300 | 0.150 |
Why?
|
| Cambodia | 1 | 2017 | 18 | 0.150 |
Why?
|
| Learning | 1 | 2019 | 171 | 0.150 |
Why?
|
| China | 1 | 2018 | 140 | 0.150 |
Why?
|
| Vitamin D | 2 | 2018 | 147 | 0.150 |
Why?
|
| Antibodies, Monoclonal | 3 | 2007 | 864 | 0.150 |
Why?
|
| Regression Analysis | 4 | 2017 | 485 | 0.150 |
Why?
|
| Homicide | 1 | 2017 | 25 | 0.150 |
Why?
|
| Schools, Medical | 3 | 2017 | 142 | 0.150 |
Why?
|
| Incidence | 5 | 2015 | 1228 | 0.150 |
Why?
|
| Prostatic Neoplasms | 1 | 2020 | 325 | 0.150 |
Why?
|
| Total Quality Management | 4 | 2003 | 57 | 0.140 |
Why?
|
| Disease Management | 2 | 2017 | 219 | 0.140 |
Why?
|
| Medication Errors | 3 | 2007 | 115 | 0.140 |
Why?
|
| Medical Order Entry Systems | 2 | 2009 | 45 | 0.140 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2017 | 96 | 0.140 |
Why?
|
| Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | 1 | 2017 | 8 | 0.140 |
Why?
|
| Diet, Mediterranean | 1 | 2017 | 32 | 0.140 |
Why?
|
| Vancomycin-Resistant Enterococci | 1 | 2017 | 10 | 0.140 |
Why?
|
| Social Marketing | 1 | 2017 | 9 | 0.140 |
Why?
|
| Smartphone | 1 | 2017 | 61 | 0.140 |
Why?
|
| Musculoskeletal Pain | 1 | 2017 | 28 | 0.140 |
Why?
|
| Early Detection of Cancer | 1 | 2020 | 260 | 0.140 |
Why?
|
| Sexual Health | 1 | 2016 | 5 | 0.140 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2017 | 29 | 0.140 |
Why?
|
| Computer Simulation | 1 | 2019 | 447 | 0.140 |
Why?
|
| Knowledge | 1 | 2017 | 30 | 0.140 |
Why?
|
| International Cooperation | 1 | 2017 | 84 | 0.140 |
Why?
|
| User-Computer Interface | 3 | 2015 | 129 | 0.140 |
Why?
|
| Bipolar Disorder | 1 | 2019 | 253 | 0.140 |
Why?
|
| Research Subjects | 1 | 2017 | 38 | 0.140 |
Why?
|
| Methods | 1 | 2016 | 39 | 0.140 |
Why?
|
| Cultural Diversity | 2 | 2015 | 51 | 0.140 |
Why?
|
| Accountable Care Organizations | 1 | 2017 | 57 | 0.130 |
Why?
|
| Child, Preschool | 1 | 2021 | 1817 | 0.130 |
Why?
|
| Social Adjustment | 1 | 2016 | 34 | 0.130 |
Why?
|
| Mother-Child Relations | 1 | 2016 | 46 | 0.130 |
Why?
|
| Bacterial Infections | 2 | 2008 | 139 | 0.130 |
Why?
|
| Non-ST Elevated Myocardial Infarction | 1 | 2016 | 32 | 0.130 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2017 | 64 | 0.130 |
Why?
|
| Calcium | 2 | 2018 | 550 | 0.130 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2006 | 249 | 0.130 |
Why?
|
| Cross-Cultural Comparison | 1 | 2016 | 45 | 0.130 |
Why?
|
| Computers, Handheld | 2 | 2006 | 30 | 0.130 |
Why?
|
| Obesity, Morbid | 1 | 2017 | 90 | 0.130 |
Why?
|
| Delayed Diagnosis | 1 | 2016 | 43 | 0.130 |
Why?
|
| Cognition Disorders | 1 | 2017 | 217 | 0.130 |
Why?
|
| Infection Control | 1 | 2017 | 93 | 0.130 |
Why?
|
| Psychotherapy, Rational-Emotive | 1 | 2015 | 3 | 0.130 |
Why?
|
| Food Supply | 1 | 2016 | 72 | 0.130 |
Why?
|
| Global Health | 1 | 2017 | 161 | 0.130 |
Why?
|
| Patient Portals | 1 | 2016 | 45 | 0.130 |
Why?
|
| Neoplasm Staging | 2 | 2020 | 451 | 0.130 |
Why?
|
| Emergency Service, Hospital | 2 | 2021 | 1016 | 0.130 |
Why?
|
| Cross Infection | 1 | 2017 | 150 | 0.130 |
Why?
|
| Decision Support Systems, Clinical | 2 | 2006 | 71 | 0.130 |
Why?
|
| Aspirin | 1 | 1996 | 186 | 0.120 |
Why?
|
| Research | 1 | 2017 | 190 | 0.120 |
Why?
|
| Patient Admission | 1 | 2017 | 184 | 0.120 |
Why?
|
| Suicidal Ideation | 1 | 2016 | 113 | 0.120 |
Why?
|
| ST Elevation Myocardial Infarction | 1 | 2016 | 72 | 0.120 |
Why?
|
| Anxiety | 2 | 2014 | 394 | 0.120 |
Why?
|
| Community-Institutional Relations | 1 | 2015 | 37 | 0.120 |
Why?
|
| Interpersonal Relations | 1 | 2016 | 150 | 0.120 |
Why?
|
| Physician's Role | 1 | 2016 | 118 | 0.120 |
Why?
|
| Gout | 2 | 2006 | 53 | 0.120 |
Why?
|
| Body Weight | 2 | 2014 | 376 | 0.120 |
Why?
|
| Depressive Disorder, Major | 1 | 2017 | 259 | 0.120 |
Why?
|
| Emergency Medicine | 1 | 2017 | 183 | 0.120 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2014 | 22 | 0.120 |
Why?
|
| Pregnancy, High-Risk | 1 | 2014 | 22 | 0.120 |
Why?
|
| Peripartum Period | 1 | 2014 | 31 | 0.120 |
Why?
|
| Skilled Nursing Facilities | 2 | 2005 | 84 | 0.110 |
Why?
|
| Reverse Transcriptase Inhibitors | 3 | 2010 | 28 | 0.110 |
Why?
|
| Databases, Factual | 5 | 2015 | 836 | 0.110 |
Why?
|
| Cell Phone | 1 | 2014 | 43 | 0.110 |
Why?
|
| Prescriptions | 2 | 2010 | 32 | 0.110 |
Why?
|
| Life Tables | 2 | 2020 | 24 | 0.110 |
Why?
|
| Crowdsourcing | 1 | 2013 | 13 | 0.110 |
Why?
|
| Academic Medical Centers | 1 | 2015 | 312 | 0.110 |
Why?
|
| Bisexuality | 1 | 2013 | 14 | 0.110 |
Why?
|
| Diphosphonates | 4 | 2007 | 34 | 0.110 |
Why?
|
| Exercise Therapy | 1 | 2014 | 97 | 0.110 |
Why?
|
| General Practice, Dental | 1 | 2013 | 6 | 0.110 |
Why?
|
| Homosexuality, Female | 1 | 2013 | 21 | 0.110 |
Why?
|
| Appointments and Schedules | 2 | 2015 | 53 | 0.110 |
Why?
|
| Telecommunications | 1 | 2013 | 9 | 0.110 |
Why?
|
| Medical Informatics Applications | 1 | 2013 | 15 | 0.110 |
Why?
|
| Computer Security | 1 | 2013 | 12 | 0.110 |
Why?
|
| Crime Victims | 1 | 2013 | 32 | 0.110 |
Why?
|
| Weight Gain | 1 | 2014 | 161 | 0.110 |
Why?
|
| Emergency Medical Services | 1 | 2016 | 249 | 0.100 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 2 | 2016 | 150 | 0.100 |
Why?
|
| Comparative Effectiveness Research | 1 | 2012 | 45 | 0.100 |
Why?
|
| Curriculum | 3 | 2011 | 541 | 0.100 |
Why?
|
| Outpatients | 2 | 2011 | 131 | 0.100 |
Why?
|
| Orthopedics | 1 | 2012 | 27 | 0.100 |
Why?
|
| Forms and Records Control | 2 | 2009 | 12 | 0.100 |
Why?
|
| Lipoproteins, LDL | 2 | 2012 | 46 | 0.100 |
Why?
|
| Prenatal Care | 1 | 2014 | 180 | 0.100 |
Why?
|
| Mouth Neoplasms | 2 | 2010 | 31 | 0.100 |
Why?
|
| Dentistry | 2 | 2008 | 9 | 0.100 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2013 | 112 | 0.100 |
Why?
|
| Preventive Health Services | 2 | 2009 | 72 | 0.100 |
Why?
|
| Sports | 1 | 2012 | 92 | 0.100 |
Why?
|
| Meditation | 1 | 2012 | 60 | 0.100 |
Why?
|
| Cost of Illness | 2 | 2015 | 154 | 0.100 |
Why?
|
| Inpatients | 1 | 2014 | 290 | 0.100 |
Why?
|
| Technology | 2 | 2022 | 48 | 0.100 |
Why?
|
| Multimedia | 1 | 2011 | 10 | 0.100 |
Why?
|
| Attitude to Computers | 2 | 2013 | 21 | 0.090 |
Why?
|
| Family Practice | 2 | 2003 | 204 | 0.090 |
Why?
|
| Sex Distribution | 5 | 2017 | 254 | 0.090 |
Why?
|
| Videotape Recording | 1 | 2011 | 46 | 0.090 |
Why?
|
| Machine Learning | 2 | 2023 | 135 | 0.090 |
Why?
|
| Videodisc Recording | 1 | 2011 | 8 | 0.090 |
Why?
|
| Ambulatory Care Facilities | 1 | 2011 | 102 | 0.090 |
Why?
|
| Community Health Services | 1 | 2012 | 128 | 0.090 |
Why?
|
| Teaching | 2 | 2009 | 152 | 0.090 |
Why?
|
| Withholding Treatment | 1 | 2011 | 39 | 0.090 |
Why?
|
| Insurance, Pharmaceutical Services | 1 | 2011 | 24 | 0.090 |
Why?
|
| Mexican Americans | 1 | 2010 | 19 | 0.090 |
Why?
|
| Zollinger-Ellison Syndrome | 1 | 2010 | 1 | 0.090 |
Why?
|
| Health Services Administration | 1 | 2010 | 4 | 0.090 |
Why?
|
| Postoperative Care | 1 | 2011 | 112 | 0.090 |
Why?
|
| Reproductive Behavior | 1 | 2010 | 4 | 0.090 |
Why?
|
| Demography | 1 | 2010 | 178 | 0.090 |
Why?
|
| Nutrition Surveys | 1 | 2011 | 152 | 0.090 |
Why?
|
| Preoperative Care | 1 | 2011 | 172 | 0.090 |
Why?
|
| Zidovudine | 1 | 2010 | 12 | 0.090 |
Why?
|
| Oral Hygiene | 1 | 2010 | 9 | 0.090 |
Why?
|
| Social Welfare | 1 | 2010 | 22 | 0.090 |
Why?
|
| International Classification of Diseases | 2 | 2008 | 142 | 0.090 |
Why?
|
| Feeding Behavior | 1 | 2012 | 314 | 0.090 |
Why?
|
| Physicians, Women | 1 | 2010 | 37 | 0.090 |
Why?
|
| Etidronic Acid | 2 | 2006 | 3 | 0.090 |
Why?
|
| Alendronate | 2 | 2006 | 14 | 0.080 |
Why?
|
| Personnel Staffing and Scheduling | 2 | 2015 | 70 | 0.080 |
Why?
|
| Anti-Retroviral Agents | 1 | 2010 | 73 | 0.080 |
Why?
|
| Patient-Centered Care | 1 | 2012 | 245 | 0.080 |
Why?
|
| Career Mobility | 1 | 2010 | 60 | 0.080 |
Why?
|
| Drug Resistance, Viral | 1 | 2011 | 154 | 0.080 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 2 | 2006 | 36 | 0.080 |
Why?
|
| Insurance Coverage | 2 | 2010 | 97 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2016 | 671 | 0.080 |
Why?
|
| Reading | 1 | 2010 | 92 | 0.080 |
Why?
|
| Prescription Drugs | 1 | 2009 | 50 | 0.080 |
Why?
|
| Mentors | 3 | 2017 | 113 | 0.080 |
Why?
|
| Public Health Informatics | 1 | 2008 | 7 | 0.080 |
Why?
|
| Urinary Incontinence | 1 | 2009 | 35 | 0.080 |
Why?
|
| Guidelines as Topic | 1 | 2010 | 158 | 0.080 |
Why?
|
| Consumer Behavior | 1 | 2009 | 35 | 0.080 |
Why?
|
| Outpatient Clinics, Hospital | 4 | 2011 | 40 | 0.080 |
Why?
|
| Vertebroplasty | 1 | 2008 | 6 | 0.080 |
Why?
|
| Fractures, Compression | 1 | 2008 | 7 | 0.080 |
Why?
|
| Drug Administration Schedule | 4 | 2010 | 280 | 0.080 |
Why?
|
| Point-of-Care Systems | 2 | 2011 | 116 | 0.080 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2009 | 56 | 0.080 |
Why?
|
| Interinstitutional Relations | 1 | 2008 | 40 | 0.080 |
Why?
|
| Drug Costs | 1 | 2009 | 58 | 0.080 |
Why?
|
| Spinal Fractures | 1 | 2008 | 37 | 0.080 |
Why?
|
| Practice Patterns, Dentists' | 1 | 2008 | 10 | 0.080 |
Why?
|
| Rheumatology | 3 | 2005 | 65 | 0.080 |
Why?
|
| Risk Adjustment | 3 | 2013 | 91 | 0.080 |
Why?
|
| Periodicals as Topic | 1 | 2011 | 170 | 0.080 |
Why?
|
| Puerto Rico | 2 | 2021 | 224 | 0.080 |
Why?
|
| Leadership | 2 | 2017 | 196 | 0.080 |
Why?
|
| Medical Informatics | 1 | 2008 | 68 | 0.080 |
Why?
|
| Physical Examination | 2 | 2015 | 103 | 0.080 |
Why?
|
| Analysis of Variance | 4 | 2013 | 576 | 0.080 |
Why?
|
| Coronary Disease | 2 | 2007 | 249 | 0.080 |
Why?
|
| Asthma | 1 | 2012 | 416 | 0.070 |
Why?
|
| Didanosine | 1 | 2007 | 3 | 0.070 |
Why?
|
| Pharmaceutical Preparations | 1 | 2009 | 121 | 0.070 |
Why?
|
| Needs Assessment | 2 | 2011 | 186 | 0.070 |
Why?
|
| Rheumatic Diseases | 1 | 2007 | 41 | 0.070 |
Why?
|
| Blood Cell Count | 1 | 2007 | 33 | 0.070 |
Why?
|
| Reimbursement Mechanisms | 1 | 2007 | 41 | 0.070 |
Why?
|
| Opportunistic Infections | 1 | 2007 | 27 | 0.070 |
Why?
|
| Treatment Refusal | 1 | 2007 | 60 | 0.070 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2007 | 66 | 0.070 |
Why?
|
| Pharyngitis | 1 | 2007 | 12 | 0.070 |
Why?
|
| Education, Continuing | 1 | 2007 | 23 | 0.070 |
Why?
|
| Faculty, Medical | 1 | 2009 | 198 | 0.070 |
Why?
|
| Endoscopy, Gastrointestinal | 2 | 2022 | 117 | 0.070 |
Why?
|
| Linear Models | 3 | 2013 | 418 | 0.070 |
Why?
|
| Biological Products | 1 | 2008 | 93 | 0.070 |
Why?
|
| Cyclooxygenase Inhibitors | 2 | 2004 | 43 | 0.070 |
Why?
|
| Legislation, Drug | 1 | 2006 | 18 | 0.070 |
Why?
|
| Secondary Prevention | 1 | 2007 | 151 | 0.070 |
Why?
|
| Allopurinol | 1 | 2006 | 17 | 0.070 |
Why?
|
| Colchicine | 1 | 2006 | 27 | 0.070 |
Why?
|
| Mammography | 2 | 1999 | 270 | 0.070 |
Why?
|
| Cataract | 1 | 2006 | 54 | 0.070 |
Why?
|
| Iatrogenic Disease | 1 | 2006 | 56 | 0.070 |
Why?
|
| Tuberculin Test | 1 | 2006 | 10 | 0.070 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2006 | 35 | 0.070 |
Why?
|
| Drug Therapy, Computer-Assisted | 1 | 2005 | 10 | 0.070 |
Why?
|
| Gout Suppressants | 1 | 2006 | 25 | 0.070 |
Why?
|
| Models, Theoretical | 1 | 2007 | 257 | 0.060 |
Why?
|
| Sampling Studies | 1 | 2005 | 66 | 0.060 |
Why?
|
| Homes for the Aged | 1 | 2007 | 164 | 0.060 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2007 | 151 | 0.060 |
Why?
|
| Adolescent Health Services | 1 | 2005 | 19 | 0.060 |
Why?
|
| Antidepressive Agents | 2 | 2024 | 227 | 0.060 |
Why?
|
| Multicenter Studies as Topic | 2 | 2020 | 115 | 0.060 |
Why?
|
| Forecasting | 2 | 2013 | 218 | 0.060 |
Why?
|
| Consent Forms | 1 | 2025 | 15 | 0.060 |
Why?
|
| Vulnerable Populations | 1 | 2006 | 83 | 0.060 |
Why?
|
| Lipids | 1 | 2007 | 302 | 0.060 |
Why?
|
| Nursing Homes | 2 | 2009 | 663 | 0.060 |
Why?
|
| Institutional Practice | 1 | 2004 | 3 | 0.060 |
Why?
|
| Single-Blind Method | 2 | 2020 | 134 | 0.060 |
Why?
|
| Directive Counseling | 1 | 2005 | 39 | 0.060 |
Why?
|
| Specialization | 1 | 2005 | 73 | 0.060 |
Why?
|
| Cardiovascular Agents | 1 | 2005 | 99 | 0.060 |
Why?
|
| Medicine | 1 | 2005 | 56 | 0.060 |
Why?
|
| Feasibility Studies | 2 | 2017 | 513 | 0.060 |
Why?
|
| Hotlines | 1 | 2024 | 22 | 0.060 |
Why?
|
| Drug Overdose | 1 | 2006 | 117 | 0.060 |
Why?
|
| Nursing, Practical | 1 | 2004 | 3 | 0.060 |
Why?
|
| Prognosis | 3 | 2019 | 1564 | 0.060 |
Why?
|
| Safety Management | 1 | 2005 | 142 | 0.060 |
Why?
|
| Private Practice | 1 | 2003 | 10 | 0.060 |
Why?
|
| Chlamydia | 1 | 2003 | 10 | 0.060 |
Why?
|
| Troponin | 1 | 2003 | 37 | 0.060 |
Why?
|
| Bahamas | 1 | 2023 | 22 | 0.060 |
Why?
|
| Safety | 1 | 2004 | 140 | 0.060 |
Why?
|
| Predictive Value of Tests | 3 | 2015 | 1021 | 0.060 |
Why?
|
| Hospitals, University | 3 | 2010 | 51 | 0.060 |
Why?
|
| Language | 1 | 2025 | 138 | 0.060 |
Why?
|
| Hemorrhage | 1 | 2005 | 276 | 0.060 |
Why?
|
| Long-Term Care | 1 | 2004 | 174 | 0.050 |
Why?
|
| Analgesics | 1 | 2004 | 100 | 0.050 |
Why?
|
| Choice Behavior | 1 | 2024 | 76 | 0.050 |
Why?
|
| Cathartics | 1 | 2023 | 11 | 0.050 |
Why?
|
| Drug Utilization Review | 1 | 2003 | 56 | 0.050 |
Why?
|
| Problem-Based Learning | 1 | 2003 | 34 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2011 | 806 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2019 | 389 | 0.050 |
Why?
|
| Nursing Staff, Hospital | 1 | 2004 | 72 | 0.050 |
Why?
|
| Heart Diseases | 1 | 2005 | 204 | 0.050 |
Why?
|
| Confidence Intervals | 3 | 2013 | 256 | 0.050 |
Why?
|
| Peer Review, Health Care | 1 | 2003 | 17 | 0.050 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2003 | 59 | 0.050 |
Why?
|
| Esophageal Sphincter, Lower | 1 | 2022 | 20 | 0.050 |
Why?
|
| Medical Staff, Hospital | 1 | 2003 | 58 | 0.050 |
Why?
|
| Manometry | 1 | 2022 | 21 | 0.050 |
Why?
|
| Safe Sex | 1 | 2022 | 25 | 0.050 |
Why?
|
| Colonoscopy | 1 | 2023 | 102 | 0.050 |
Why?
|
| Registries | 2 | 2019 | 800 | 0.050 |
Why?
|
| Health Planning | 1 | 2002 | 28 | 0.050 |
Why?
|
| Infliximab | 3 | 2007 | 52 | 0.050 |
Why?
|
| Age Distribution | 2 | 2017 | 261 | 0.050 |
Why?
|
| Schools | 1 | 2023 | 156 | 0.050 |
Why?
|
| Interviews as Topic | 3 | 2010 | 480 | 0.050 |
Why?
|
| Severity of Illness Index | 3 | 2017 | 1444 | 0.050 |
Why?
|
| Cardiology | 2 | 2019 | 164 | 0.050 |
Why?
|
| Carbon Monoxide | 1 | 2022 | 59 | 0.050 |
Why?
|
| Alcohol Drinking | 1 | 2024 | 294 | 0.050 |
Why?
|
| Hematologic Tests | 1 | 2001 | 14 | 0.050 |
Why?
|
| Decision Making | 2 | 2017 | 382 | 0.050 |
Why?
|
| Acute Disease | 1 | 2003 | 654 | 0.050 |
Why?
|
| General Practice | 1 | 2021 | 15 | 0.050 |
Why?
|
| Tobacco Smoking | 1 | 2021 | 19 | 0.050 |
Why?
|
| Dental Research | 2 | 2013 | 10 | 0.050 |
Why?
|
| Multimorbidity | 1 | 2021 | 38 | 0.050 |
Why?
|
| Marital Status | 1 | 2020 | 43 | 0.050 |
Why?
|
| SEER Program | 1 | 2020 | 65 | 0.050 |
Why?
|
| Delphi Technique | 2 | 2011 | 81 | 0.050 |
Why?
|
| Chi-Square Distribution | 2 | 2013 | 402 | 0.040 |
Why?
|
| Spouses | 1 | 2020 | 38 | 0.040 |
Why?
|
| Long Term Adverse Effects | 1 | 2019 | 3 | 0.040 |
Why?
|
| Hospitals, Maternity | 1 | 2019 | 10 | 0.040 |
Why?
|
| Puerperal Disorders | 1 | 2019 | 13 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2021 | 2014 | 0.040 |
Why?
|
| Reward | 1 | 2020 | 80 | 0.040 |
Why?
|
| Suburban Population | 1 | 2019 | 9 | 0.040 |
Why?
|
| Goals | 1 | 2020 | 89 | 0.040 |
Why?
|
| Cardiologists | 1 | 2019 | 25 | 0.040 |
Why?
|
| Physician Assistants | 1 | 2019 | 37 | 0.040 |
Why?
|
| Subject Headings | 1 | 1999 | 2 | 0.040 |
Why?
|
| Clinical Medicine | 1 | 1999 | 16 | 0.040 |
Why?
|
| Utilization Review | 1 | 1999 | 31 | 0.040 |
Why?
|
| Substance-Related Disorders | 2 | 2021 | 688 | 0.040 |
Why?
|
| Social Norms | 1 | 2018 | 9 | 0.040 |
Why?
|
| Insurance Claim Reporting | 1 | 1998 | 18 | 0.040 |
Why?
|
| Fees and Charges | 1 | 1998 | 18 | 0.040 |
Why?
|
| Documentation | 1 | 2019 | 127 | 0.040 |
Why?
|
| Medically Uninsured | 2 | 2009 | 40 | 0.040 |
Why?
|
| Health Care Reform | 1 | 1998 | 88 | 0.040 |
Why?
|
| Risk | 2 | 2010 | 370 | 0.040 |
Why?
|
| Survival Rate | 2 | 2011 | 786 | 0.040 |
Why?
|
| Carrier State | 1 | 2017 | 18 | 0.040 |
Why?
|
| Viral Load | 2 | 2010 | 228 | 0.040 |
Why?
|
| Osteoarthritis, Hip | 1 | 2017 | 29 | 0.040 |
Why?
|
| Etanercept | 2 | 2007 | 31 | 0.040 |
Why?
|
| Capacity Building | 1 | 2017 | 22 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor | 2 | 2007 | 61 | 0.040 |
Why?
|
| Organizational Policy | 1 | 2017 | 54 | 0.040 |
Why?
|
| Databases as Topic | 2 | 2007 | 53 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 2 | 2008 | 95 | 0.030 |
Why?
|
| Epidemiologic Methods | 2 | 2008 | 68 | 0.030 |
Why?
|
| Software | 1 | 2000 | 364 | 0.030 |
Why?
|
| Sex Education | 1 | 2016 | 23 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 2 | 2006 | 104 | 0.030 |
Why?
|
| Diuretics | 1 | 2016 | 58 | 0.030 |
Why?
|
| Body Image | 1 | 2016 | 28 | 0.030 |
Why?
|
| Weight Reduction Programs | 1 | 2016 | 57 | 0.030 |
Why?
|
| Video Recording | 1 | 2016 | 123 | 0.030 |
Why?
|
| Self-Help Groups | 1 | 2015 | 37 | 0.030 |
Why?
|
| Cooperative Behavior | 1 | 2017 | 217 | 0.030 |
Why?
|
| Inservice Training | 1 | 2015 | 81 | 0.030 |
Why?
|
| Blood Glucose | 2 | 2012 | 467 | 0.030 |
Why?
|
| Immunoglobulin G | 2 | 2007 | 450 | 0.030 |
Why?
|
| Heart Rate | 1 | 2016 | 302 | 0.030 |
Why?
|
| Transcultural Nursing | 1 | 2014 | 2 | 0.030 |
Why?
|
| Neoplasms | 1 | 2004 | 1221 | 0.030 |
Why?
|
| Absorptiometry, Photon | 1 | 2014 | 87 | 0.030 |
Why?
|
| Elective Surgical Procedures | 1 | 2015 | 104 | 0.030 |
Why?
|
| Health | 1 | 2014 | 32 | 0.030 |
Why?
|
| Time-to-Treatment | 1 | 2015 | 98 | 0.030 |
Why?
|
| Heart Arrest | 1 | 2016 | 155 | 0.030 |
Why?
|
| Biomechanical Phenomena | 1 | 2015 | 240 | 0.030 |
Why?
|
| Recurrence | 1 | 2015 | 575 | 0.030 |
Why?
|
| Afghan Campaign 2001- | 1 | 2013 | 54 | 0.030 |
Why?
|
| Iraq War, 2003-2011 | 1 | 2013 | 57 | 0.030 |
Why?
|
| Cardiac Catheterization | 2 | 2006 | 239 | 0.030 |
Why?
|
| Hospital Charges | 1 | 2013 | 23 | 0.030 |
Why?
|
| Osteoporotic Fractures | 1 | 2013 | 29 | 0.030 |
Why?
|
| Pregnant Women | 1 | 2014 | 92 | 0.030 |
Why?
|
| Sex Offenses | 1 | 2013 | 46 | 0.030 |
Why?
|
| United States Agency for Healthcare Research and Quality | 1 | 2012 | 30 | 0.030 |
Why?
|
| Patient Dropouts | 1 | 2012 | 48 | 0.030 |
Why?
|
| Tobacco Products | 1 | 2013 | 75 | 0.030 |
Why?
|
| Qualitative Research | 1 | 2016 | 598 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2013 | 553 | 0.020 |
Why?
|
| Veterans Health | 1 | 2013 | 156 | 0.020 |
Why?
|
| Respiratory Function Tests | 1 | 2012 | 165 | 0.020 |
Why?
|
| Reoperation | 1 | 2012 | 247 | 0.020 |
Why?
|
| Interprofessional Relations | 1 | 2012 | 130 | 0.020 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2013 | 114 | 0.020 |
Why?
|
| Length of Stay | 1 | 2014 | 760 | 0.020 |
Why?
|
| Writing | 1 | 2010 | 43 | 0.020 |
Why?
|
| Peru | 1 | 2010 | 12 | 0.020 |
Why?
|
| Evidence-Based Practice | 1 | 2010 | 82 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 207 | 0.020 |
Why?
|
| Feedback | 2 | 2001 | 87 | 0.020 |
Why?
|
| HIV | 1 | 2010 | 69 | 0.020 |
Why?
|
| Pharmaceutical Services | 1 | 2010 | 31 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 2009 | 38 | 0.020 |
Why?
|
| Pharmacy Service, Hospital | 1 | 2009 | 22 | 0.020 |
Why?
|
| Group Practice | 1 | 2009 | 12 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2011 | 209 | 0.020 |
Why?
|
| Kyphosis | 1 | 2008 | 5 | 0.020 |
Why?
|
| Education | 1 | 2009 | 74 | 0.020 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2009 | 48 | 0.020 |
Why?
|
| Models, Educational | 1 | 2009 | 62 | 0.020 |
Why?
|
| Therapy, Computer-Assisted | 1 | 2008 | 24 | 0.020 |
Why?
|
| Professional Role | 1 | 2008 | 37 | 0.020 |
Why?
|
| Thoracic Vertebrae | 1 | 2008 | 33 | 0.020 |
Why?
|
| RNA, Viral | 1 | 2010 | 265 | 0.020 |
Why?
|
| Education, Dental, Continuing | 1 | 2008 | 4 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2010 | 433 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2009 | 89 | 0.020 |
Why?
|
| Personnel Selection | 1 | 2008 | 45 | 0.020 |
Why?
|
| Patient Advocacy | 1 | 2008 | 31 | 0.020 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2008 | 74 | 0.020 |
Why?
|
| Arizona | 1 | 2007 | 14 | 0.020 |
Why?
|
| North Carolina | 1 | 2007 | 65 | 0.020 |
Why?
|
| HIV Protease Inhibitors | 1 | 2008 | 106 | 0.020 |
Why?
|
| Fatigue | 1 | 2008 | 103 | 0.020 |
Why?
|
| Telemetry | 1 | 2007 | 20 | 0.020 |
Why?
|
| Platelet Count | 1 | 2007 | 33 | 0.020 |
Why?
|
| Dyslipidemias | 1 | 2007 | 34 | 0.020 |
Why?
|
| Decision Trees | 1 | 2007 | 50 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2007 | 140 | 0.020 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2007 | 39 | 0.020 |
Why?
|
| Adalimumab | 1 | 2007 | 35 | 0.020 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2007 | 20 | 0.020 |
Why?
|
| Lumbar Vertebrae | 1 | 2008 | 142 | 0.020 |
Why?
|
| Insulin | 1 | 2011 | 682 | 0.020 |
Why?
|
| Methotrexate | 1 | 2007 | 76 | 0.020 |
Why?
|
| Hormones | 1 | 2006 | 57 | 0.020 |
Why?
|
| ROC Curve | 1 | 2007 | 259 | 0.020 |
Why?
|
| Immunocompromised Host | 1 | 2007 | 93 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2006 | 115 | 0.020 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2007 | 80 | 0.020 |
Why?
|
| Ambulatory Care Information Systems | 1 | 2005 | 8 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2007 | 139 | 0.020 |
Why?
|
| Accreditation | 1 | 2006 | 69 | 0.020 |
Why?
|
| Crohn Disease | 1 | 2007 | 105 | 0.020 |
Why?
|
| Cytoprotection | 1 | 2005 | 18 | 0.020 |
Why?
|
| Health Services for the Aged | 1 | 2006 | 48 | 0.020 |
Why?
|
| Antigens, Bacterial | 1 | 2007 | 211 | 0.020 |
Why?
|
| Physician Executives | 1 | 2005 | 28 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2007 | 291 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2006 | 168 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2006 | 344 | 0.020 |
Why?
|
| Nurse Administrators | 1 | 2005 | 19 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2007 | 216 | 0.020 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2005 | 43 | 0.020 |
Why?
|
| Heparin | 1 | 2006 | 113 | 0.020 |
Why?
|
| Educational Measurement | 1 | 2006 | 206 | 0.010 |
Why?
|
| Gastroenterology | 1 | 2005 | 52 | 0.010 |
Why?
|
| Risk Management | 1 | 2004 | 39 | 0.010 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2006 | 106 | 0.010 |
Why?
|
| Communication Barriers | 1 | 2004 | 55 | 0.010 |
Why?
|
| HIV-1 | 1 | 2010 | 706 | 0.010 |
Why?
|
| Stereotyping | 1 | 2004 | 18 | 0.010 |
Why?
|
| Epidemiological Monitoring | 1 | 2003 | 25 | 0.010 |
Why?
|
| Mid-Atlantic Region | 1 | 2003 | 2 | 0.010 |
Why?
|
| Critical Pathways | 1 | 2004 | 29 | 0.010 |
Why?
|
| Health Benefit Plans, Employee | 1 | 2003 | 11 | 0.010 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2003 | 32 | 0.010 |
Why?
|
| Medicare Part A | 1 | 2003 | 6 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2003 | 77 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2003 | 134 | 0.010 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2003 | 141 | 0.010 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2003 | 165 | 0.010 |
Why?
|
| Environmental Monitoring | 1 | 2003 | 139 | 0.010 |
Why?
|
| New England | 1 | 2003 | 267 | 0.010 |
Why?
|
| Echocardiography | 1 | 2006 | 455 | 0.010 |
Why?
|
| Models, Organizational | 1 | 2003 | 91 | 0.010 |
Why?
|
| Disease Progression | 1 | 2006 | 1031 | 0.010 |
Why?
|
| Models, Biological | 1 | 2007 | 1137 | 0.010 |
Why?
|
| Diabetic Foot | 1 | 2001 | 11 | 0.010 |
Why?
|
| Radiography | 1 | 2003 | 505 | 0.010 |
Why?
|
| Urban Health | 1 | 2001 | 43 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2007 | 712 | 0.010 |
Why?
|
| Influenza Vaccines | 1 | 2001 | 88 | 0.010 |
Why?
|
| Cholesterol | 1 | 2001 | 256 | 0.010 |
Why?
|
| Triglycerides | 1 | 2001 | 244 | 0.010 |
Why?
|
| Bayes Theorem | 1 | 1999 | 108 | 0.010 |
Why?
|
| Biomarkers | 1 | 2003 | 1200 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2003 | 839 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 1999 | 1113 | 0.010 |
Why?
|